IP82: Sexual Function/Dysfunction: Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM · 2 hr. (America/New_York)
146C
Poster and Podium Sessions
Sexual Function
Monday, May 18
IP82-03: Novel transplant of human Peyronie’s plaque into immunocompromised rodent phallus recapitulates human Peyronie’s disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Yunah Kim
IP82-01: Examining the roles of NELL1 and CDTSPL as regulators of fibrosis
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Michael Christensen · University of Utah
IP82-02: Cross-dataset meta-analysis defining consensus differential gene expression in Peyronie’s disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Ilaha Isali
IP82-04: Scar Wars: Therapeutic targets Vs. Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
ChingHao Chen · King’s College London, UK
IP82-05: Tissue markers of collagenase response in Peyronie’s disease: role of vimentin and collagen type 1/type 3 ratio
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Juan Ignacio Martinez Salamanca · Lyx Institute of Urology
IP82-06: Analysis of Therapeutic Efficacy of Low-Intensity Pulsed Ultrasound in a Rat Model of Peyronie's Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Hongji Hu
IP82-07: Exploring the Relationship Between Lipid Dysregulation and Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Daniel Turin · University of Minnesota Medical School
IP82-08: Risk of Peyronie’s Disease Following Intracavernosal Injections for Erectile Dysfunction
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Daniel Greenberg
IP82-09: Angle vs. Patient: Underutilization of Patient-Reported Outcomes in Peyronie’s Disease Randomized Controlled Trials
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Thriaksh Rajan
IP82-10: Validation of the PTNM Classification System for Peyronie’s Disease Subtypes and Stability
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
William Fuell
IP82-11: Prospective inter-observer validation of the PTNM classification system for Peyronie’s disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Juan Ignacio Martinez Salamanca · Lyx Institute of Urology
IP82-12: National Trends in Utilization, Costs, and Reimbursement for Peyronie’s Disease Treatments in the Medicare Population, 2013-2023
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Elie Kaplan-Marans · Maimonides Health
IP82-13: Placebo effect in intralesional injection therapy for Peyronie’s disease: a systematic review and meta-analysis of published prospective clinical trials
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Sara Baldini · ASST Sette Laghi - Circolo & Fondazione Macchi Hospital, Varese (Italy)
IP82-14: Impact of Testosterone on Treatment Outcomes in Peyronie’s Disease: A Multicenter Retrospective Analysis of Collagenase Clostridium Histolyticum Therapy
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Beatriz Hernandez · Baylor College of Medicine
IP82-15: Efficacy of Collagenase Clostridium histolyticum in Active versus Stable Peyronie’s Disease Phases
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Thairo Alves Pereira
IP82-16: Final Results of a Multicenter, Retrospective Analysis of Collagenase Clostridium Histolyticum (CCH) for Ventral Penile Curvature in Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Jesse Mills · UCLA
IP82-17: Efficacy of a Novel Collagenase Clostridium Histolyticum Protocol for Peyronie’s Disease Among Prior Non-responders: A Randomized, Controlled, Single-Blinded Study
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Ryan Nigbur
IP82-18: Delayed Dose Collagenase Clostridium Histolyticum Protocol for Men with Peyronie’s Disease: A Prospective Clinical Study
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Landon Trost · Male Fertility and Peyronie's Clinic
IP82-19: Trends in Penile Fracture and Repair after Intralesional Collagenase Clostridium Histolyticum for Peyronie's Disease: An Analysis of the MarketScan Database 2014-2024
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Ellen Cahill · Yale University School of Medicine
IP82-20: A Contemporary Approach in the Treatment of Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Charles Lee · Mayo clinic
IP82-21: Comparison of Collagenase Clostridium Histolyticum to Surgery for the Management of Peyronie’s Disease: A Randomized Trial – 3 Year Outcomes
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Alissa Tyler · Male Fertility and Peyronie's Clinic
IP82-22: The Impact of Collagenase Clostridium Histolyticum (CCH) Priming on Surgical Outcomes in Peyronie's Disease: A Retrospective Cohort Study
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Beatriz Hernandez · Baylor College of Medicine
IP82-23: The use of EVARREST® fibrin patch as a grafting material in Peyronie’s surgery
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Benjamin Fink
IP82-24: Functional Outcomes of Dehydrated Amniotic Membrane Use in Plaque Incision and Grafting for Peyronie's Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Lance Earnshaw
IP82-25: Corporoplasty for Peyronie’s disease and congenital penile curvature: real-world effectiveness, safety, and patient-reported outcomes at a single tertiary-referral center
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Massimiliano Raffo
IP82-26: Polyglycolic Acid Polymer Versus Porcine Small Intestine Submucosa Graft After Plaque Incision in Peyronie’s Disease: A Comparative Study
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Leonardo Seligra-Lopes · Centro Univeristario FMABC
IP82-27: Less is More: Outcomes of Tunical Plication for Correction of Penile Curvature with Minimal Permanent Suture Use, a 10 Year Review
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Oren Feldmanschultz · Rush University
IP82-28: Decision Regret in Patients Following Penile Prosthesis Insertion for Severe Peyronie's Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Jack Hay
IP82-29: Timing-Dependent Effects of Postoperative Maximal Inflation Protocol on Penile Curvature Resolution Following Modeling: A Multivariable and Interaction Analysis
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Britney Atwater
IP82-30: Beyond the Primary Curve: Directional Improvements in Secondary Penile Curvature Following Inflatable Penile Prosthesis Placement for Peyronie’s Disease
Monday, May 18, 2026 9:30 AM to 11:30 AM
146C
Muhammed Alaa Moukhtar Hammad · Department of Urology, University of California, Irvine
